Intravenous Gammaglobulin for Sickle Cell Pain Crises

This study is currently recruiting participants.

Verified December 2012 by Albert Einstein College of Medicine of Yeshiva University

Sponsor:

Collaborator:

Food and Drug Administration (FDA)

Information provided by (Responsible Party):

Deepa Manwani, Albert Einstein College of Medicine of Yeshiva University

ClinicalTrials.gov Identifier:

NCT01757418

First received: November 8, 2012

Last updated: December 21, 2012

Last verified: December 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	July 2014 (Final data collection date for primary outcome measure)